U
HPTX

UBS’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

UBS’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$100K Buy
3,978
+3,307
+493% +$82.1K ﹤0.01% 6005
2014
Q2 		$18K Buy
671
+602
+872% +$15.5K ﹤0.01% 8240
2014
Q1 		$2K Sell
69
-448
-87% -$12.1K ﹤0.01% 10137
2013
Q4 		$10K Buy
+517
New +$12.2K ﹤0.01% 9046

Other funds holding HPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

UBS's HPTX Position: Q3 2014 in Review

UBS increased its HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) stake by 493% in Q3 2014, buying an estimated $82.1K and bringing the position to 3,978 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #6005.

UBS first reported a position in HPTX in Q4 2013 and has held it in 4 quarters since. 97 funds tracked by Wall St. Rank hold HPTX as of Q3 2014.

  • UBS held 3,978 shares of HYPERION THERAPEUTICS INC COM STK (DE) worth $100K as of Q3 2014.
  • UBS bought 3,307 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $82.1K.
  • HYPERION THERAPEUTICS INC COM STK (DE) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6005 holding.
  • UBS first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2013 and has held it in 4 quarters since.
  • 97 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.